New heart valve could transform tricuspid treatment

NCT ID NCT05742906

Recruiting now Disease control Sponsor: Corvivo Cardiovascular, Inc. Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times

Summary

This study is testing a new valve (Cor TRICUSPID ECM Valve) for people with tricuspid heart valve disease. About 92 adults and children will receive the valve during surgery and be followed for up to 5 years. The goal is to see if the valve is safe and works well to fix the damaged valve.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRICUSPID VALVE INSUFFICIENCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Columbia University Irving Medical Center/New York Presbyterian
RECRUITING

New York, New York, 10032, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••
St Francis Hospital
RECRUITING

Indianapolis, Indiana, 46237, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact

Conditions

Explore the condition pages connected to this study.

TRICUSPID VALVE DISEASE TRICUSPID VALVE INSUFFICIENCY